Drug firm USV and bio-tech company Biogenomics have launched INSUQUICK, India's first biosimilar Insulin Aspart. INSUQUICK is a 'Make in India' product, developed and manufactured using indigenous ...

Mumbai: USV Pvt Ltd and Biogenomics announced the launch of INSUQUICK, India’s first biosimilar insulin aspart, which will improve access for people with diabetes. InsuQuick is a ‘Make in India’ ...

Insulin aspart promises to be the stepping stone for USV’s entry into the insulin market, it claimed. USV Pvt Ltd and Biogenomics on Wednesday announced the launch of INSUQUICK, India’s first ...

A veteran in diabetes drugs, USV has partnered with biotech venture Biogenomics to bring out InsuQuick, the first locally-made biosimilar version of Insulin Aspart. The partnership marks USV’s entry ...

The production of the kits is going on with full steam ahead and these will be available for use in the next few weeks RT-PCR testing kits jointly developed by specialty diagnostic firm iGenetic ...

USV and Biogenomics introduced Insuquick, a rapid-acting insulin biosimilar for revolutionising diabetes care USV's focus areas to remain cardiology & diabetes, plans to introduce nutraceuticals for ...

New Delhi: RT-PCR testing kits jointly developed by iGenetic Diagnostics and Biogenomics have received approval from the Indian Council of Medical Research (ICMR) and the National Institute of ...

Two Indian firms iGenetic Diagnostics and BioGenomics have claimed to have jointly developed RT-PCR testing kits for COVID-19 with 100% concordance to true positives and true negatives. The testing ...

NEW DELHI: As the country becomes self-reliant in manufacturing RT-PCR testing kits, adding to the arsenal in India's fight against COVID-19, Mumbai-based speciality diagnostic company iGenetic ...

RT-PCR testing kits jointly developed by specialty diagnostic firm iGenetic Diagnostics and biopharmaceutical firm Biogenomics have received approval from the Indian Council of Medical Research and ...